Pharmaceutical sales jobs continue to grow. Average salary for a pharmaceutical sales rep in the is about $98,000 according to the Chicago Tribune.
AIDS physician groups tell pharmaceutical companies to lower the price of their drugs and expand access to their medicines, expanding co-pays, ensuring formulary coverage.
Pharmaceutical companies becoming more transparent? GlaxoSmithKline plans to open up much of its drug research in an apparent effort to deflect criticism that important information gathered in clinical trials often does not see the light of day.
Big Pharma’s image problem, fueled by numerous high-profile scandals, may have made doctors so skeptical of the industry that it’s warping their judgment, a new survey suggests, according to Reuters Health.
Consumer Reports’ annual prescription drug poll finds that many American consumers rely on multiple prescription drugs and are so strapped for cash that they can’t afford to pay for them.
Pharmas collaborating increasingly with universities. Novartis and the University of Pennsylvania announced a research and licensing agreement that aims to bring to market a new approach to fighting cancer that has shown promising results in early trials.
Forbes reports on drug rebates: the free market is alive and well when it comes to drug prices – if you’re an insurance company or a government program. But not if you’re a consumer.
Pfizer Inc., the drugmaker that’s fired 26,000 workers in three years, is cutting its employee severance package after May 14, according to an internal memo.
European governments are sacrificing the long-term future of science in their countries for the sake of short-term budget cuts, Pfizer chief executive Ian Read told Reuters. Europe is undermining drug innovation by cutting prices, raising barriers to new medicines and freeloading” off others in Asia and the United States who are more willing to pay.